✦ LIBER ✦

A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients

✍ Scribed by Hiroshi Sakai; Shuichi Yoneda; Tomohide Tamura; Yutaka Nishiwaki; Akira Yokoyama; Koshiro Watanabe; Nagahiro Saijo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine, ifosfamide and paclitaxel i

✍ F. V. Piantedosi; F. Caputo; G. Mazzarella; M. Gilli; A. Pontillo; D. D’Agostino 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 206 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Phase II study of weekly docetaxel combi

✍ Toshiyuki Tsunoda; Tomonobu Koizumi; Muneharu Hayasaka; Kazuya Hirai; Shigeru Ko 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Alternating weekly administration of pac

✍ David Aguiar; José Aguiar; Uriel Bohn 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB

Phase II study with fractionated schedul

✍ Jung Hye Kwon; Jung Han Kim; Jung-Ae Lee; Hyun Chun Shin; Hyo Jung Kim; Hun Ho S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 193 KB

Phase II study of the combination of vin

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Keigo Tominaga 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 169 KB